FibroGen's competitors

FibroGen's competitors include BioTime, CanSino Biologics, Flex Pharma and Pieris Pharmaceuticals
Add company...
FibroGen
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
BioTime
BioTime is a biotechnology company focused on biomedical research and product development in regenerative medicine.
CanSino Biologics
CanSino Biologics is a biotechnology company dedicated to the R&D, manufacturing, and commercialization of vaccine products for human use.
Flex Pharma
Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.
Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.
Founding Date
Founding Date
1993
Founding Date
1990
Founding Date
2009
Founding Date
2014
Founding Date
2001
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Locations
Alameda, US HQ
Locations
Tianjin, CN HQ
Locations
Boston, US HQ
Locations
Boston, US HQ
Employees
Employees
364
Employees
133 303% increase
Employees
166,741
Employees
30 19% decrease
Employees
49 29% increase
Valuation ($)
Valuation ($)
3.5 b
Valuation ($)
280.2 m
Valuation ($)
N/A
Valuation ($)
66.2 m
Valuation ($)
246.3 m
Facebook followers
Facebook followers
68
Facebook followers
1.2 k
Facebook followers
N/A
Facebook followers
2.1 k
Facebook followers
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
842
Twitter followers
N/A
Twitter followers
428
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$179.6m (FY, 2016)
Revenue (est.)
$5.9m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$1m (FY, 2016)
Revenue (est.)
$5.8m (FY, 2016)
Net income
Net income
($61.7m) (FY, 2016)
Net income
$18.6m (FY, 2016)
Net income
N/A
Net income
($8m) (FY, 2016)
Net income
($22.8m) (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles